Search company, investor...

Founded Year

2020

Stage

Biz Plan Competition | Alive

Total Raised

$1.13M

Last Raised

$1M | 3 mos ago

About Trestle Biotherapeutics

Trestle Biotherapeutics develops an implantable therapeutic tissue that can be surgically delivered to patients suffering from end-stage renal disease. Its services offer the development of functional therapeutic tissue for patients suffering from chronic kidney disease through the integration of stem cell biology and bio-fabrication. The company was founded in 2023 and is based in San Diego, California.

Headquarters Location

9276 Scranton Road

San Diego, California, 92121,

United States

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Expert Collections containing Trestle Biotherapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Trestle Biotherapeutics is included in 1 Expert Collection, including Y Combinator W21 Demo Day.

Y

Y Combinator W21 Demo Day

445 items

Latest Trestle Biotherapeutics News

Trestle Biotherapeutics Wins Prestigious KidneyX Prize

Jun 12, 2023

SAN DIEGO--(BUSINESS WIRE)--Trestle Biotherapeutics today received a $1 million prize from the KidneyX Innovation Accelerator through the organization’s Artificial Kidney Prize program. Trestle is one of eight Artificial Kidney Prize Phase 2 winners announced today. Trestle was recognized for their innovative approach in developing bioengineered kidney tissues for patients living with kidney failure through the integration of cutting-edge techniques in stem cell biology and 3D biofabrication. T

Trestle Biotherapeutics Frequently Asked Questions (FAQ)

  • When was Trestle Biotherapeutics founded?

    Trestle Biotherapeutics was founded in 2020.

  • Where is Trestle Biotherapeutics's headquarters?

    Trestle Biotherapeutics's headquarters is located at 9276 Scranton Road, San Diego.

  • What is Trestle Biotherapeutics's latest funding round?

    Trestle Biotherapeutics's latest funding round is Biz Plan Competition.

  • How much did Trestle Biotherapeutics raise?

    Trestle Biotherapeutics raised a total of $1.13M.

  • Who are the investors of Trestle Biotherapeutics?

    Investors of Trestle Biotherapeutics include KidneyX Artificial Kidney Prize, Wellcome Leap HOPE Program, Y Combinator, Black Mountain Ventures, Formic Ventures and 5 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.